Chicago Atlantic Real Estate Finance is no longer trying to win as a standalone cannabis mortgage REIT. Management signed an all-stock, net-asset-value-for-net-asset-value combination into affiliated Chicago Atlantic BDC in June, arguing that the public REIT wrapper cannot deliver the capital-markets access the platform wants. The equity now prices a conversion story more than a coupon story. Second-quarter distributable earnings of $0.44 on a basic share basis fell short of the regular quarterly dividend. That gap is small in cash terms and large in meaning, because the board still declared the same forty-seven-cent check and later reaffirmed it for the third quarter.
The coverage miss looks like a timing problem and behaves like a structural one. Early-period repayments left cash idle while new loans funded late, so net interest income slipped even as loan principal climbed to $453 million. Pricing power inside the cannabis credit niche is not the issue here. Gross unlevered yield held near sixteen percent, which is still a private-credit coupon that conventional mortgage REITs do not earn. What is fading is the standalone REIT's ability to recycle a high payout while the book turns over. The pending BDC conversion is management's answer to that constraint.
After quarter-end the company issued roughly four million new shares at book to buy a $63 million second-lien package on thirty-two cannabis retail properties from Koach Capital. That deal adds duration and subordination just as the merger exchange ratio is about to be set. The live debate is whether shareholders are being paid to wait for a larger BDC, or whether they are funding a related-party recut of a yield vehicle whose coverage is already slipping. Does the year-end close actually improve the residual claim, or does it merely change the ticker on the same concentrated cannabis book?